Introduction
Numerous potential neuronal imaging agents based on the neuronal monoamine reuptake system have been developed, and several of these [["Clcocaine, Fowler et al. (1989) ; ["Clnomifensine, Salmon et al. (1990) ; ['*F]GBR 12909, Koeppe et al. (1990) ] are currently being evaluated in human subjects using positron emission tomography (PET). The imaging of vesicular neurotransmitter uptake sites would form an alternative method for quantification of neuronal densities.
Tetrabenazine (TBZ) is a high affinity [IC& = 3 nM, Scherman et al. (1988a) ] specific inhibitor of the monoamine transporter of the presynaptic vesicular membrane, and shows more CNS specificity, a shorter duration of monoamine depletion and a greater selectivity for depletion of brain catecholamines (dopamine and norepinephrine > serotonin) as compared to reserpine (Pettibone et al., 1984; Scherman, 1986; Henry and Scherman, 1989) . ['HlDihydrotetrabenazine ([3H] TBZOH) has been recently used as a radioligand for in vitro homogenate and autoradiographic studies of the monoamine vesicular transporter, and shows high specific binding in the striatum of rodents (Scherman et al., 1988b) . In 6-hydroxydopamine-lesioned rats, loss of [3H]TBZOH sites correlated well with loss of tyrosine hydroxylase activity (Masuo et al., 1990) , and postmortem studies of brains of patients with Parkinson's disease revealed lower binding of ['HITBZOH in the *Author for correspondence.
caudate nucleus and the putamen (-73 and -87%) as compared to controls (Scherman et al., 1989) .
Tetrabenazine
is thus a potential candidate for development as a new PET radiotracer to measure losses of dopaminergic neurons in neurodegenerative disorders, such as Parkinson's disease. The high binding affinity, moderate lipophilicity [log P = 2.68, Scherman et al. (1988a) ] and low toxicity (Pletscher et al., 1962) of this clinically used drug is particularly encouraging.
Development of related labeled benzoquinolizine derivatives for single photon emission computed tomography (SPECT) imaging is being pursued by others (Canney et al., 1993) . We report here the synthesis of tetrabenazine in carbon-l 1 form as a potential radioligand for studying monoaminergic terminal losses in neurological diseases using PET.
Materials

Experimental
Tetrabenazine was purchased from Fluka and boron triiodide was obtained from Johnson Matthey Chemicals Ltd; all other chemicals and solvents were obtained from Aldrich Chem. Co., and were used without further purification.
Sep-Pak C,, cartridges were purchased from Waters Associates. Thin-layer chromatography was performed on 0.25 mm Whatman glass-backed silica gel plates (60A K6F), with CHCl,/methanol (24/l) as eluting solvent mixture. Semi-preparative HPLC was done using a Partisil 10 silica gel column (10 mm, 25 x 0.94 cm) eluted with CH,Cl,/hexane/isopropanol 85/14/l at a flow rate of 6 mL/min. The HPLC system was fitted with in-line detectors for U.V. (286 nm) and radioactivity (y-detector). 'H-NMR chemical shifts are reported relative to tetramethylsilane as an internal reference. Low-resolution mass spectrum (MS) and high-resolution mass spectrum (HRMS) were determined in the chemical ionization mode (ammonia); data are expressed in m/z (intensity relative to base peak = 100). Elemental analysis was performed by Spang Microanalytical Laboratory, Eagle Arbor, MI.
2-0x0-3-isobutyl-9-hydroxy-IO-methoxy-1, 3, 4, 6, 2) Tetrabenazine (1, 3.77 g, 11.9 mmol) was dissolved in dichloromethane (IO mL), a N, atmosphere introduced and the mixture cooled to -76C in a dry ice/isopropanol bath. A solution of BI, (95%, 4.9 g, 1 equiv.) in CH,Cl, (23.8 mL) was added dropwise over 5-IOmin.
After stirring for 5 min at room temperature, the reaction was quenched with a saturated aqueous solution (100 mL) of NaHCO, containing sodium bisulfite. The aqueous layer was extracted with CH,Cl, (3 x 150 mL) and the extracts dried over Na,SO,, filtered and evaporated to dryness The residue was purified (3 x) by column chromatography (280 g silica gel, gradient CHCl,/methanol 99/l-CHCl,/methanol 99/5) to give 2 as an oil. DesmethylTBZ (2) was further purified by semi-preparative HPLC (CH,Cl,/hexane/isopropanol 50/49/l, 4 mL/min, t, = 11.6 min) and dried over KOH under vacuum to provide an oil (72 mg, 2 %): Found: 304.1900; anal. calcd for C,BH,,NO,: C, 71.26; H, 8.31; N, 4.62. Found: C, 71.31; H, 8.34 ; N, 4.55.
Production of ["C]methyl iodide
["C]Carbon dioxide was produced via the "N(p,a)"C reaction using nitrogen in an allaluminum target.
["CICO, was then converted to ["C]methyl iodide by LiAIH, reduction followed by treatment with HI (Crouzel et al., 1987; Jewett, 1987) .
Synthesis of ["CITBZ (["C]I)
["ClTetrabenazine was prepared by O-["Clmethylation of desmethylTBZ with ["Clmethyl iodide (Fig. l) , utilizing the apparatus used for the synthesis of ["C]( + )2a-tropanylbenzilate (Mulholland et al., 1992) . ["C]Methyl iodide was trapped in a reaction vessel containing desmethylTBZ (free base, 1.0 mg) and tetrabutylammonium hydroxide (TBAOH, MeOH solution, 1.8 mL, 0.55 equiv.) in DMF (200 mL) at -30 to -40°C. After heating at 20°C for 5 min, water (0.5 mL) was added to the mixture and the solution was transferred onto a short reversed phase column filled with C,, Sep-Pak packing that was pre-washed with MeOH (50 mL) and water (100 mL). The extraction column was rinsed with water (1 .O mL) and blown dry with Nz (80 psi) for 2 min. The HPLC solvent was then passed through this short column onto a silica gel semi-preparative HPLC column. The radioactive peak corresponding to ["CITBZ (tR = 9.0 min; phenol 2, t, = >20 min) was collected into a sterile vial placed in a warm water bath (30-4O"C) and the solvent removed by N, flow. The residue was formulated in a sterile solution of isotonic phosphate buffer (pH 6.0) and then filtered through a 0.2 pm alumina filter (Anotop) into a sterile 10mL multidose vial (yield 35-55%, decay corrected). 
Analyses of [ "Cl1
HPLC. An showed two methoxy groups at 3.83 and 3.86ppm, whereas that of desmethylTBZ exhibited only one methoxy group at 3.89 ppm. The presence of only one methoxy signal for 2 indicates that the demethylation with BI, was selective, however, it does not tell which methoxy group had been cleaved. The assignment of the hydroxyl and the methoxyl group was determined by comparing the chemical shifts of the aromatic protons of TBZ and desmethylTBZ with the published NMR spectra of structurally similar demethylated derivatives of protoberberines.
The two aromatic protons of desmethylTBZ isolated in this work show singlets at 6 720 and 6 6.64, consistent with the chemical shifts at 67.43 and 66.53 observed for dehydrodiscretine [3; Chen et al. (198O) 4: 66.78 and 66.58; Yu et al. (1970) ], which represents an analogue with the other methoxy group cleaved (Fig. 2) . Tetrabenazine, with both methoxy groups intact, shows singlets at 66.55 and 66.62. Based on these comparisons, we have assigned the hydroxyl group to C-9 and the methoxyl group to C-10 in the desmethylTBZ isolated in this work.
Results and Discussion
Synthesis of ["Cltetrabenazine Preparation cf desmethylTBZ
The demethylation of TBZ was carried out in low yields (2-10%) using BI, in dichloromethane (Lansinger and Ronald, 1979) . The product was repeatedly purified by column chromatography and HPLC until completely free of contamination with unreacted TBZ or catechol; this extensive purification accounted for part of the overall low yield of this synthesis. Demethylation of TBZ with BBr, gave a mixture of both 9-and IO-desmethylTBZ in poor yields, while almost no demethylation occurred with iodotrimethylsilane (McOmie et al., 1968; Vickery et al., 1979) . Although the overall yield was low, demethylation of TBZ was faster and more convenient than the optional total synthesis of desmethylTBZ.
Assignment of the structure of desmethylTBZ (2)
The structure of desmethylTBZ (2) was determined using a combination of 'H-NMR, MS, HRMS and elemental analysis. The 'H-NMR spectrum of TBZ ["CITBZ was successfully synthesized in high radiochemical yields (35-55%, decay corrected based on ["C]CO,) and high specific activities (2000-2500Ci/mmol, end of synthesis) within 32-37min from end of beam in high chemical and radiochemical purities (> 95%). Higher radiochemical yields could be obtained in the production of ["CITBZ by adding more TBAOH or by increasing the reaction temperature, but more side products were also formed. However, using 0.55 equiv. of base (TBAOH) in DMF at room temperature gave only a few percent of side products and acceptable yields of ["CITBZ. 
